Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 7883 | 4.24 |
09:36 ET | 840 | 4.27 |
09:38 ET | 100 | 4.3 |
09:41 ET | 270 | 4.2876 |
09:43 ET | 600 | 4.2671 |
09:45 ET | 570 | 4.28 |
09:48 ET | 100 | 4.3 |
09:50 ET | 100 | 4.31 |
09:52 ET | 1000 | 4.3 |
09:54 ET | 700 | 4.34 |
09:56 ET | 2638 | 4.32 |
09:57 ET | 700 | 4.3 |
10:01 ET | 285 | 4.305 |
10:03 ET | 707 | 4.285 |
10:06 ET | 221 | 4.2696 |
10:08 ET | 200 | 4.2702 |
10:10 ET | 433 | 4.275 |
10:12 ET | 100 | 4.28 |
10:14 ET | 600 | 4.27 |
10:15 ET | 100 | 4.27 |
10:17 ET | 2814 | 4.27 |
10:19 ET | 530 | 4.28 |
10:21 ET | 155 | 4.2901 |
10:24 ET | 100 | 4.3 |
10:26 ET | 900 | 4.29 |
10:28 ET | 1100 | 4.295 |
10:30 ET | 400 | 4.29 |
10:32 ET | 543 | 4.3 |
10:33 ET | 9490 | 4.25 |
10:35 ET | 2903 | 4.245 |
10:37 ET | 1211 | 4.24 |
10:42 ET | 262 | 4.24 |
10:44 ET | 100 | 4.24 |
10:46 ET | 1000 | 4.24 |
10:48 ET | 400 | 4.25 |
10:50 ET | 955 | 4.215 |
10:51 ET | 2100 | 4.2 |
10:53 ET | 500 | 4.2 |
10:55 ET | 100 | 4.21 |
10:57 ET | 100 | 4.21 |
11:00 ET | 300 | 4.21 |
11:02 ET | 200 | 4.21 |
11:04 ET | 3213 | 4.195 |
11:06 ET | 100 | 4.18 |
11:08 ET | 100 | 4.18 |
11:09 ET | 100 | 4.195 |
11:11 ET | 400 | 4.195 |
11:15 ET | 311 | 4.19 |
11:18 ET | 700 | 4.19 |
11:22 ET | 100 | 4.175 |
11:24 ET | 500 | 4.1636 |
11:26 ET | 265 | 4.16 |
11:27 ET | 100 | 4.175 |
11:29 ET | 4724 | 4.19 |
11:31 ET | 300 | 4.16 |
11:33 ET | 450 | 4.1897 |
11:36 ET | 700 | 4.18 |
11:40 ET | 2676 | 4.22 |
11:42 ET | 759 | 4.22 |
11:45 ET | 200 | 4.23 |
11:47 ET | 100 | 4.23 |
11:49 ET | 100 | 4.23 |
11:51 ET | 1386 | 4.21 |
11:54 ET | 100 | 4.19 |
11:58 ET | 200 | 4.2 |
12:00 ET | 300 | 4.21 |
12:02 ET | 300 | 4.21 |
12:07 ET | 100 | 4.195 |
12:09 ET | 551 | 4.18 |
12:12 ET | 300 | 4.19 |
12:14 ET | 100 | 4.19 |
12:16 ET | 500 | 4.2 |
12:27 ET | 3615 | 4.19 |
12:32 ET | 500 | 4.205 |
12:34 ET | 200 | 4.2 |
12:36 ET | 500 | 4.19 |
12:39 ET | 500 | 4.19 |
12:43 ET | 686 | 4.189 |
12:45 ET | 200 | 4.18 |
12:48 ET | 300 | 4.19 |
12:50 ET | 1127 | 4.17 |
12:54 ET | 200 | 4.16 |
12:56 ET | 1131 | 4.17 |
01:01 ET | 100 | 4.17 |
01:03 ET | 800 | 4.185 |
01:06 ET | 307 | 4.19 |
01:14 ET | 715 | 4.175 |
01:15 ET | 550 | 4.18 |
01:17 ET | 100 | 4.185 |
01:19 ET | 300 | 4.19 |
01:26 ET | 200 | 4.21 |
01:30 ET | 200 | 4.2 |
01:35 ET | 100 | 4.2 |
01:37 ET | 926 | 4.18 |
01:46 ET | 300 | 4.17 |
01:50 ET | 1242 | 4.16 |
01:51 ET | 2194 | 4.16 |
01:53 ET | 100 | 4.16 |
02:00 ET | 600 | 4.16 |
02:02 ET | 732 | 4.14 |
02:04 ET | 800 | 4.13 |
02:06 ET | 300 | 4.14 |
02:08 ET | 100 | 4.13 |
02:09 ET | 100 | 4.13 |
02:11 ET | 700 | 4.14 |
02:13 ET | 300 | 4.14 |
02:18 ET | 171 | 4.131 |
02:20 ET | 1800 | 4.14 |
02:22 ET | 2105 | 4.12 |
02:24 ET | 200 | 4.11 |
02:27 ET | 1491 | 4.1184 |
02:29 ET | 2418 | 4.15 |
02:31 ET | 200 | 4.14 |
02:36 ET | 1728 | 4.15 |
02:38 ET | 1300 | 4.138 |
02:42 ET | 100 | 4.15 |
02:44 ET | 200 | 4.13 |
02:45 ET | 300 | 4.14 |
02:47 ET | 100 | 4.13 |
02:49 ET | 2215 | 4.16 |
02:51 ET | 1072 | 4.2 |
02:54 ET | 100 | 4.19 |
02:56 ET | 100 | 4.19 |
02:58 ET | 2282 | 4.1999 |
03:02 ET | 400 | 4.18 |
03:03 ET | 606 | 4.2 |
03:05 ET | 1175 | 4.2 |
03:07 ET | 100 | 4.21 |
03:09 ET | 200 | 4.21 |
03:14 ET | 300 | 4.2 |
03:16 ET | 700 | 4.2 |
03:18 ET | 898 | 4.2 |
03:20 ET | 5855 | 4.18 |
03:21 ET | 11905 | 4.19 |
03:23 ET | 100 | 4.19 |
03:25 ET | 386 | 4.19 |
03:30 ET | 5962 | 4.19 |
03:32 ET | 100 | 4.19 |
03:34 ET | 100 | 4.19 |
03:36 ET | 777 | 4.199 |
03:38 ET | 200 | 4.2 |
03:41 ET | 6667 | 4.21 |
03:43 ET | 3878 | 4.19 |
03:45 ET | 1233 | 4.175 |
03:48 ET | 1000 | 4.17 |
03:50 ET | 200 | 4.175 |
03:52 ET | 5331 | 4.16 |
03:54 ET | 334 | 4.165 |
03:56 ET | 5459 | 4.175 |
03:57 ET | 814 | 4.175 |
03:59 ET | 7224 | 4.18 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 477.6M | -2.2x | --- |
Verve Therapeutics Inc | 470.2M | -1.9x | --- |
Adlai Nortye Ltd | 470.5M | -1.8x | --- |
Fulcrum Therapeutics Inc | 479.2M | -4.8x | --- |
Ocugen Inc | 442.6M | -7.3x | --- |
Corbus Pharmaceuticals Holdings Inc | 480.5M | -6.5x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $477.6M |
---|---|
Revenue (TTM) | $-477.0K |
Shares Outstanding | 114.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.87 |
EPS | $-1.91 |
Book Value | $-0.20 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.